About Zolares
Overview
Zolares is a Cyprus-registered financial services entity, founded on 24 June 2021. The broker operates under the domain zolares.com and appears to target retail traders seeking access to forex and CFD markets. However, as of this review, Zolares does not hold any recognised regulatory licences from major financial authorities.
Traders considering Zolares should be aware that the absence of regulatory oversight significantly increases counterparty risk. The broker's registration in Cyprus, a jurisdiction often associated with higher-risk brokers, does not imply authorisation by the Cyprus Securities and Exchange Commission (CySEC) or any other regulator. Given the limited public information available, FXCanary advises extreme caution.
Regulation and Safety
Our records indicate that Zolares has no regulators on file. This means the broker is not supervised by any known financial watchdog, such as CySEC, FCA, or ASIC. Without regulatory oversight, there are no mandatory requirements for client fund segregation, negative balance protection, or dispute resolution mechanisms.
In FXCanary's assessment, the lack of regulation is a major red flag. Traders should verify any claims of licensing independently and consider the heightened risk of dealing with an unregulated entity. The broker's 48/100 'Guarded' risk score reflects this concern.
Company Background
Zolares was established in Cyprus in mid-2021, but beyond its registration date and country, little verifiable information is publicly available. The company's ownership, management team, and operational history are not disclosed on its website or in accessible public records.
This opacity makes it difficult for traders to assess the credibility and reliability of the broker. In the absence of transparent corporate information, we recommend treating Zolares as a high-risk proposition.
Account Types and Trading Conditions
Due to the lack of web search results and the broker's own website being inaccessible in our review, we cannot confirm the specific account types, spreads, commissions, or leverage offered by Zolares. Typically, unregulated brokers may offer high leverage and flexible terms, but this also carries elevated risk.
Traders should be cautious: without verified information, any claims made by the broker about account conditions should be treated as unsubstantiated. We advise seeking brokers with transparent and regulated trading environments.
Deposits and Withdrawals
No information is available regarding the payment methods accepted by Zolares or the processing times for deposits and withdrawals. Unregulated brokers often have less stringent processes, which can lead to delays or difficulties in retrieving funds.
Industry experience suggests that unregulated entities may impose hidden fees or restrictive withdrawal policies. Until Zolares provides clear, verifiable information, traders should assume the worst-case scenario regarding fund access.
Customer Support
We were unable to evaluate the quality of customer support at Zolares due to the lack of contact information or responsive channels. Typically, unregulated brokers may offer limited support, often via email or a contact form without live chat or phone lines.
Without reliable customer service, resolving disputes or technical issues becomes challenging. This is a further consideration for potential clients, as poor support can compound the risks of trading with an unregulated broker.
Conclusion for Introductory Purposes
Zolares presents itself as a forex and CFD broker based in Cyprus, but the absence of regulatory licences and scant public information make it a particularly risky choice for traders. The broker's 48/100 risk score indicates that while it may not be an outright scam, the lack of oversight and transparency warrants a guarded approach.
Traders seeking a secure trading environment should prioritise regulated brokers with a proven track record. For those considering Zolares, thorough due diligence is essential – and even then, the risks may outweigh any potential benefits.
Overview compiled by FXCanary from regulatory records and public data. full Zolares review